Secukinumab decreased circulating anti‐ <scp>BP</scp> 180‐ <scp>NC</scp> 16a autoantibodies in a patient with coexisting psoriasis vulgaris and bullous pemphigoid

Authors :: Rino Shida
Yoshihide Asano
Tomomitsu Miyagaki
Yayoi Tada
Narumi Maeda
Tomohiko Kawashima
Ayumi Yoshizaki
Shinichi Sato
Masahiro Kamata
Source :: The Journal of Dermatology. 46:e216-e217
Publication Year :: 2019
Publisher :: Wiley, 2019.

Subjects :: medicine.medical_specialty
Pemphigoid
biology
business.industry
Treatment outcome
Autoantibody
Dermatology
General Medicine
medicine.disease
Psoriasis
Monoclonal
medicine
biology.protein
Secukinumab
Bullous pemphigoid
Antibody
business

Tools